Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 164 Pages
Report ld: 6468649
Request Sample
Customized Report
COVID-19 Antigen Rapid Test Cassette Market Size(US$)

CAGR 2026-2032
-20.1%
Market Size,2032
USD 4,403
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global COVID-19 Antigen Rapid Test Cassette market was valued at US$ 20660 million in 2025 and is anticipated to reach US$ 4403 million by 2032, at a CAGR of -20.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on COVID-19 Antigen Rapid Test Cassette competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
The North American market for COVID-19 Antigen Rapid Test Cassette is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for COVID-19 Antigen Rapid Test Cassette is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of COVID-19 Antigen Rapid Test Cassette include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, AESKU.GROUP, ROCHE, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global COVID-19 Antigen Rapid Test Cassette market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding COVID-19 Antigen Rapid Test Cassette. The COVID-19 Antigen Rapid Test Cassette market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global COVID-19 Antigen Rapid Test Cassette market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist COVID-19 Antigen Rapid Test Cassette manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for COVID-19 Antigen Rapid Test Cassette manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines COVID-19 Antigen Rapid Test Cassette sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 COVID-19 Antigen Rapid Test Cassette Market Overview
1.1 Product Definition
1.2 COVID-19 Antigen Rapid Test Cassette by Type
1.2.1 Global COVID-19 Antigen Rapid Test Cassette Market Value by Type: 2025 vs 2032
1.2.2 Fluorescence Immunochromatography
1.2.3 Colloidal Gold Immunochromatography
1.2.4 Latex Immunochromatography
1.2.5 Others
1.3 COVID-19 Antigen Rapid Test Cassette by Application
1.3.1 Global COVID-19 Antigen Rapid Test Cassette Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Home
1.3.4 School
1.3.5 Third-Party Detection Institution
1.3.6 Others
1.4 Global COVID-19 Antigen Rapid Test Cassette Market Size Estimates and Forecasts
1.4.1 Global COVID-19 Antigen Rapid Test Cassette Revenue 2021–2032
1.4.2 Global COVID-19 Antigen Rapid Test Cassette Sales 2021–2032
1.4.3 Global COVID-19 Antigen Rapid Test Cassette Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 COVID-19 Antigen Rapid Test Cassette Market Competition by Manufacturers
2.1 Global COVID-19 Antigen Rapid Test Cassette Sales Market Share by Manufacturers (2021–2026)
2.2 Global COVID-19 Antigen Rapid Test Cassette Revenue Market Share by Manufacturers (2021–2026)
2.3 Global COVID-19 Antigen Rapid Test Cassette Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of COVID-19 Antigen Rapid Test Cassette, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of COVID-19 Antigen Rapid Test Cassette, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of COVID-19 Antigen Rapid Test Cassette, Product Types and Applications
2.7 Global Key Manufacturers of COVID-19 Antigen Rapid Test Cassette, Date of Entry into the Industry
2.8 Global COVID-19 Antigen Rapid Test Cassette Market Competitive Situation and Trends
2.8.1 Global COVID-19 Antigen Rapid Test Cassette Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global COVID-19 Antigen Rapid Test Cassette Players Market Share by Revenue
2.8.3 Global COVID-19 Antigen Rapid Test Cassette Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COVID-19 Antigen Rapid Test Cassette Market Scenario by Region
3.1 Global COVID-19 Antigen Rapid Test Cassette Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global COVID-19 Antigen Rapid Test Cassette Sales by Region: 2021–2032
3.2.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Region: 2021–2026
3.2.2 Global COVID-19 Antigen Rapid Test Cassette Sales by Region: 2027–2032
3.3 Global COVID-19 Antigen Rapid Test Cassette Revenue by Region: 2021–2032
3.3.1 Global COVID-19 Antigen Rapid Test Cassette Revenue by Region: 2021–2026
3.3.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Region: 2027–2032
3.4 North America COVID-19 Antigen Rapid Test Cassette Market Facts & Figures by Country
3.4.1 North America COVID-19 Antigen Rapid Test Cassette Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America COVID-19 Antigen Rapid Test Cassette Sales by Country (2021–2032)
3.4.3 North America COVID-19 Antigen Rapid Test Cassette Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe COVID-19 Antigen Rapid Test Cassette Market Facts & Figures by Country
3.5.1 Europe COVID-19 Antigen Rapid Test Cassette Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe COVID-19 Antigen Rapid Test Cassette Sales by Country (2021–2032)
3.5.3 Europe COVID-19 Antigen Rapid Test Cassette Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COVID-19 Antigen Rapid Test Cassette Market Facts & Figures by Region
3.6.1 Asia Pacific COVID-19 Antigen Rapid Test Cassette Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific COVID-19 Antigen Rapid Test Cassette Sales by Region (2021–2032)
3.6.3 Asia Pacific COVID-19 Antigen Rapid Test Cassette Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America COVID-19 Antigen Rapid Test Cassette Market Facts & Figures by Country
3.7.1 Latin America COVID-19 Antigen Rapid Test Cassette Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America COVID-19 Antigen Rapid Test Cassette Sales by Country (2021–2032)
3.7.3 Latin America COVID-19 Antigen Rapid Test Cassette Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Market Facts & Figures by Country
3.8.1 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Sales by Country (2021–2032)
3.8.3 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Type (2021–2032)
4.1.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Type (2021–2026)
4.1.2 Global COVID-19 Antigen Rapid Test Cassette Sales by Type (2027–2032)
4.1.3 Global COVID-19 Antigen Rapid Test Cassette Sales Market Share by Type (2021–2032)
4.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Type (2021–2032)
4.2.1 Global COVID-19 Antigen Rapid Test Cassette Revenue by Type (2021–2026)
4.2.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Type (2027–2032)
4.2.3 Global COVID-19 Antigen Rapid Test Cassette Revenue Market Share by Type (2021–2032)
4.3 Global COVID-19 Antigen Rapid Test Cassette Price by Type (2021–2032)
5 Segment by Application
5.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Application (2021–2032)
5.1.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Application (2021–2026)
5.1.2 Global COVID-19 Antigen Rapid Test Cassette Sales by Application (2027–2032)
5.1.3 Global COVID-19 Antigen Rapid Test Cassette Sales Market Share by Application (2021–2032)
5.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Application (2021–2032)
5.2.1 Global COVID-19 Antigen Rapid Test Cassette Revenue by Application (2021–2026)
5.2.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Application (2027–2032)
5.2.3 Global COVID-19 Antigen Rapid Test Cassette Revenue Market Share by Application (2021–2032)
5.3 Global COVID-19 Antigen Rapid Test Cassette Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Quidel
6.2.1 Quidel Company Information
6.2.2 Quidel Description and Business Overview
6.2.3 Quidel COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Quidel COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.2.5 Quidel Recent Developments/Updates
6.3 ACCESS BIO
6.3.1 ACCESS BIO Company Information
6.3.2 ACCESS BIO Description and Business Overview
6.3.3 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.3.5 ACCESS BIO Recent Developments/Updates
6.4 CTK Biotech
6.4.1 CTK Biotech Company Information
6.4.2 CTK Biotech Description and Business Overview
6.4.3 CTK Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CTK Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.4.5 CTK Biotech Recent Developments/Updates
6.5 SD Biosensor
6.5.1 SD Biosensor Company Information
6.5.2 SD Biosensor Description and Business Overview
6.5.3 SD Biosensor COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SD Biosensor COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.5.5 SD Biosensor Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Company Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ellume COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 InBios
6.7.1 InBios Company Information
6.7.2 InBios Description and Business Overview
6.7.3 InBios COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 InBios COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.7.5 InBios Recent Developments/Updates
6.8 Celltrion
6.8.1 Celltrion Company Information
6.8.2 Celltrion Description and Business Overview
6.8.3 Celltrion COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Celltrion COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.8.5 Celltrion Recent Developments/Updates
6.9 AESKU.GROUP
6.9.1 AESKU.GROUP Company Information
6.9.2 AESKU.GROUP Description and Business Overview
6.9.3 AESKU.GROUP COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AESKU.GROUP COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.9.5 AESKU.GROUP Recent Developments/Updates
6.10 ROCHE
6.10.1 ROCHE Company Information
6.10.2 ROCHE Description and Business Overview
6.10.3 ROCHE COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ROCHE COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.10.5 ROCHE Recent Developments/Updates
6.11 BD
6.11.1 BD Company Information
6.11.2 BD Description and Business Overview
6.11.3 BD COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BD COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.11.5 BD Recent Developments/Updates
6.12 OraSure Technologies
6.12.1 OraSure Technologies Company Information
6.12.2 OraSure Technologies Description and Business Overview
6.12.3 OraSure Technologies COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 OraSure Technologies COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.12.5 OraSure Technologies Recent Developments/Updates
6.13 Clip Health
6.13.1 Clip Health Company Information
6.13.2 Clip Health Description and Business Overview
6.13.3 Clip Health COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Clip Health COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.13.5 Clip Health Recent Developments/Updates
6.14 LumiraDx
6.14.1 LumiraDx Company Information
6.14.2 LumiraDx Description and Business Overview
6.14.3 LumiraDx COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 LumiraDx COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.14.5 LumiraDx Recent Developments/Updates
6.15 Princeton BioMeditech Corporation
6.15.1 Princeton BioMeditech Corporation Company Information
6.15.2 Princeton BioMeditech Corporation Description and Business Overview
6.15.3 Princeton BioMeditech Corporation COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Princeton BioMeditech Corporation COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.15.5 Princeton BioMeditech Corporation Recent Developments/Updates
6.16 RapiGEN Inc.
6.16.1 RapiGEN Inc. Company Information
6.16.2 RapiGEN Inc. Description and Business Overview
6.16.3 RapiGEN Inc. COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 RapiGEN Inc. COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.16.5 RapiGEN Inc. Recent Developments/Updates
6.17 Orient Gene
6.17.1 Orient Gene Company Information
6.17.2 Orient Gene Description and Business Overview
6.17.3 Orient Gene COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Orient Gene COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.17.5 Orient Gene Recent Developments/Updates
6.18 Wondfo Biotech
6.18.1 Wondfo Biotech Company Information
6.18.2 Wondfo Biotech Description and Business Overview
6.18.3 Wondfo Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Wondfo Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.18.5 Wondfo Biotech Recent Developments/Updates
6.19 Ihealth (Andon Health)
6.19.1 Ihealth (Andon Health) Company Information
6.19.2 Ihealth (Andon Health) Description and Business Overview
6.19.3 Ihealth (Andon Health) COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Ihealth (Andon Health) COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.19.5 Ihealth (Andon Health) Recent Developments/Updates
6.20 Wantai BioPharm
6.20.1 Wantai BioPharm Company Information
6.20.2 Wantai BioPharm Description and Business Overview
6.20.3 Wantai BioPharm COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Wantai BioPharm COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.20.5 Wantai BioPharm Recent Developments/Updates
6.21 Biotest Biotech
6.21.1 Biotest Biotech Company Information
6.21.2 Biotest Biotech Description and Business Overview
6.21.3 Biotest Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Biotest Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.21.5 Biotest Biotech Recent Developments/Updates
6.22 Shenzhen YHLO Biotech
6.22.1 Shenzhen YHLO Biotech Company Information
6.22.2 Shenzhen YHLO Biotech Description and Business Overview
6.22.3 Shenzhen YHLO Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shenzhen YHLO Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.22.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.23 Vazyme Biotech
6.23.1 Vazyme Biotech Company Information
6.23.2 Vazyme Biotech Description and Business Overview
6.23.3 Vazyme Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Vazyme Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.23.5 Vazyme Biotech Recent Developments/Updates
6.24 EasyDiagnosis Biomedicine
6.24.1 EasyDiagnosis Biomedicine Company Information
6.24.2 EasyDiagnosis Biomedicine Description and Business Overview
6.24.3 EasyDiagnosis Biomedicine COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 EasyDiagnosis Biomedicine COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.24.5 EasyDiagnosis Biomedicine Recent Developments/Updates
6.25 Beijing Hotgen Biotech
6.25.1 Beijing Hotgen Biotech Company Information
6.25.2 Beijing Hotgen Biotech Description and Business Overview
6.25.3 Beijing Hotgen Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Beijing Hotgen Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.25.5 Beijing Hotgen Biotech Recent Developments/Updates
6.26 Assure Tech
6.26.1 Assure Tech Company Information
6.26.2 Assure Tech Description and Business Overview
6.26.3 Assure Tech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Assure Tech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.26.5 Assure Tech Recent Developments/Updates
6.27 Hangzhou AllTest Biotech
6.27.1 Hangzhou AllTest Biotech Company Information
6.27.2 Hangzhou AllTest Biotech Description and Business Overview
6.27.3 Hangzhou AllTest Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Hangzhou AllTest Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.27.5 Hangzhou AllTest Biotech Recent Developments/Updates
6.28 ACON Biotech
6.28.1 ACON Biotech Company Information
6.28.2 ACON Biotech Description and Business Overview
6.28.3 ACON Biotech COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 ACON Biotech COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.28.5 ACON Biotech Recent Developments/Updates
6.29 BGI Genomics
6.29.1 BGI Genomics Company Information
6.29.2 BGI Genomics Description and Business Overview
6.29.3 BGI Genomics COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 BGI Genomics COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.29.5 BGI Genomics Recent Developments/Updates
6.30 Lepu Medical Technology
6.30.1 Lepu Medical Technology Company Information
6.30.2 Lepu Medical Technology Description and Business Overview
6.30.3 Lepu Medical Technology COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.30.4 Lepu Medical Technology COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.30.5 Lepu Medical Technology Recent Developments/Updates
6.31 Jinwofu Bioengineering Technology
6.31.1 Jinwofu Bioengineering Technology Company Information
6.31.2 Jinwofu Bioengineering Technology Description and Business Overview
6.31.3 Jinwofu Bioengineering Technology COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.31.4 Jinwofu Bioengineering Technology COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.31.5 Jinwofu Bioengineering Technology Recent Developments/Updates
6.32 Phase Scientific
6.32.1 Phase Scientific Company Information
6.32.2 Phase Scientific Description and Business Overview
6.32.3 Phase Scientific COVID-19 Antigen Rapid Test Cassette Sales, Revenue, and Gross Margin (2021–2026)
6.32.4 Phase Scientific COVID-19 Antigen Rapid Test Cassette Product Portfolio
6.32.5 Phase Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COVID-19 Antigen Rapid Test Cassette Industry Chain Analysis
7.2 COVID-19 Antigen Rapid Test Cassette Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COVID-19 Antigen Rapid Test Cassette Production Mode & Process Analysis
7.4 COVID-19 Antigen Rapid Test Cassette Sales and Marketing
7.4.1 COVID-19 Antigen Rapid Test Cassette Sales Channels
7.4.2 COVID-19 Antigen Rapid Test Cassette Distributors
7.5 COVID-19 Antigen Rapid Test Cassette Customer Analysis
8 COVID-19 Antigen Rapid Test Cassette Market Dynamics
8.1 COVID-19 Antigen Rapid Test Cassette Industry Trends
8.2 COVID-19 Antigen Rapid Test Cassette Market Drivers
8.3 COVID-19 Antigen Rapid Test Cassette Market Challenges
8.4 COVID-19 Antigen Rapid Test Cassette Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 20660 million in 2025 and is projected to reach US$ 4403 million, growing at a CAGR of -20.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 180
USD 3950.00
(Single User License)
The global COVID-19 Antigen Rapid Test Cassette market size was US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 139
USD 4250.00
(Single User License)
The global COVID-19 Antigen Rapid Test Cassette market is projected to grow from US$ 25220 million in 2024 to US$ 5376 million by 2031, at a CAGR of -20.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 221
USD 4900.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 209
USD 3950.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was valued at US$ 25220 million in the year 2024 and is projected to reach a revised size of US$ 5376 million by 2031, growing at a CAGR of -20.1% during the forecast period.
Published Date: 2025-01-13
Pages: 129
USD 2900.00
(Single User License)
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published Date: 2024-04-28
Pages: 125
USD 4900.00
(Single User License)
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published Date: 2024-02-05
Pages: 109
USD 2900.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 20660 million in 2025 and is projected to reach US$ 4403 million, growing at a CAGR of -20.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 180
The global COVID-19 Antigen Rapid Test Cassette market size was US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 139
The global COVID-19 Antigen Rapid Test Cassette market is projected to grow from US$ 25220 million in 2024 to US$ 5376 million by 2031, at a CAGR of -20.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 221
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 209
The global market for COVID-19 Antigen Rapid Test Cassette was valued at US$ 25220 million in the year 2024 and is projected to reach a revised size of US$ 5376 million by 2031, growing at a CAGR of -20.1% during the forecast period.
Published: 2025-01-13
Pages: 129
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published: 2024-04-28
Pages: 125
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published: 2024-02-05
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now